Posts tagged Ph.D. Program
Loren D. Walensky, M.D., Ph.D.

Loren D. Walensky, M.D., Ph.D., is a chemical biologist and pediatric oncologist, whose innovative work in creating stapled peptides for use in cancer and other disease applications contributed to the founding of Aileron Therapeutics. His ongoing work employs this groundbreaking peptide-stapling strategy to produce diverse anticancer peptides to deactivate disease-causing apoptotic and transcriptional pathways in a variety of human tumors, and he also remains deeply committed to pediatric oncology care. Dr. Walensky joined the Dana-Farber and Harvard Medical School faculty as Instructor of Pediatrics in 2003, founded his independent research laboratory as Assistant Professor in 2006, and was promoted to Associate Professor in 2011 and Full Professor in 2016. Dr. Walensky is the recipient of numerous awards including an NIH Director’s Transformative Research RO1 Award, a Burroughs Wellcome Career Award in the Biomedical Sciences, the E. Mead Johnson Award for Pediatric Research, and an NCI Outstanding Investigator R35 Award. He is a member of the American Society for Clinical Investigation, the Society for Pediatric Research, and the American Pediatric Society. Dr. Walensky received his M.D and Ph.D. degrees from the Johns Hopkins University School of Medicine.

Read More